Remicade Biosimilars Market - Size, Share, Growth and Outlook, Analysis, 2018-2026
Biosimilars are almost identical copies of the originally approved drugs and can be manufactured only when the patent for the original innovator drug expires.
Biosimilars are almost identical copies of the originally approved drugs and can be manufactured only when the patent for the original innovator drug expires.
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
<strong>Remicade</strong> <strong>Biosimilars</strong> <strong>Market</strong> -<br />
GLOBAL INDUSTRY INSIGHTS, TRENDS, OUTLOOK,<br />
AND OPPORTUNITY ANALYSIS, 2017-2025<br />
© Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION<br />
<strong>Remicade</strong> <strong>Biosimilars</strong> <strong>Market</strong> – Overview<br />
Biosimilar refers to biotherapeutic product that is similar in terms of quality, efficacy, <strong>and</strong> safety to an<br />
existing licensed reference therapeutic drug. Biological products are the fastest growing class of<br />
therapeutic products, as they offer additional treatment options <strong>and</strong> help in lowering healthcare costs.<br />
<strong>Biosimilars</strong> are almost identical copies of the originally approved drugs <strong>and</strong> can be manufactured only<br />
when the patent for the original innovator drug expires. These products are highly sensitive to smallest<br />
changes in manufacturing procedure, as these drugs possess high molecular complexity. <strong>Remicade</strong><br />
(Infliximab) refers to a chimeric monoclonal antibody biologic licensed by U.S. FDA in 1998, as an<br />
innovative product indicated for the treatment of Crohn’s disease in adults <strong>and</strong> children.<br />
The monoclonal antibody drug was first developed in partnership by Janssen Biotech, Inc. <strong>and</strong> Merck &<br />
Co. The <strong>Remicade</strong> was later approved for its use in the treatment of ulcerative colitis, plague psoriasis,<br />
rheumatic arthritis, <strong>and</strong> spinal psoriatic arthritis in combination with methotrexate. Later, various<br />
pharmaceutical manufacturers developed biosimilars to infliximab, which lowered market share of<br />
<strong>Remicade</strong> due to cost-effective prices.<br />
© Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION<br />
<strong>Remicade</strong> <strong>Biosimilars</strong> <strong>Market</strong> Taxonomy:<br />
On the basis of disease indication:<br />
●<br />
●<br />
●<br />
●<br />
●<br />
●<br />
Ulcerative Colitis<br />
Rheumatoid Arthritis<br />
Ankylosing Spondylitis<br />
Crohn’s Disease<br />
Psoriatic Arthritis<br />
Plaque Psoriasis<br />
Request for a sample copy @ https://www.coherentmarketinsights.com/insight/request-sample/1769<br />
© Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION<br />
<strong>Remicade</strong> <strong>Biosimilars</strong> <strong>Market</strong>: Key Players<br />
●<br />
●<br />
●<br />
●<br />
●<br />
●<br />
●<br />
Janssen Biotech, Inc.<br />
Merck <strong>and</strong> Company, Inc.<br />
Alvogen.<br />
Pfizer, Inc.<br />
Celltrion.<br />
Nippon Kayaku.<br />
Napp Pharmaceuticals.<br />
View this report @<br />
https://www.coherentmarketinsights.com/ongoing-insight/remicade-biosimilars-market-1769<br />
© Coherent market Insights. All Rights Reserved
ABOUT COHERENT MARKET INSIGHTS<br />
ABOUT US<br />
Coherent <strong>Market</strong> Insights is a global market intelligence <strong>and</strong> consulting organization<br />
focused on assisting its plethora of clients achieve transformational growth by helping<br />
them make critical business decisions. We are headquartered in India, with an office at<br />
the global financial capital in the U.S. Our client base includes players from across all<br />
business verticals in over 150 countries worldwide. We are uniquely positioned to help<br />
businesses around the globe deliver practical <strong>and</strong> lasting results through various<br />
recommendations about operational improvements, technologies, emerging market<br />
trends <strong>and</strong> new working methods. We offer both customized <strong>and</strong> syndicated market<br />
research reports that help our clients create visionary growth plans to provide traction to<br />
their business. We meticulously study emerging trends across various industries at both<br />
the global <strong>and</strong> regional levels to identify new opportunities for our clientele.<br />
SERVICES<br />
INDUSTRY ANALYSIS<br />
MARKET INTELLIGENCE<br />
SERVICES<br />
CUSTOMIZED<br />
RESEARCH<br />
CONSULT STUDIES<br />
SYNDICATED RESEARCH<br />
COUNTRY SPECIFIC<br />
STUDIES<br />
© Coherent market Insights. All Rights Reserved
ABOUT COHERENT MARKET INSIGHTS<br />
SECTOR COVERAGE<br />
Healthcare<br />
CLINICAL DIAGNOSTIC<br />
HEALTHCARE IT<br />
MEDICAL DEVICES<br />
MEDICAL IMAGING<br />
Chemicals & Materials<br />
PHARMACEUTICAL<br />
Bulk Chemicals Advanced Materials Speciality <strong>and</strong> Fine Chemicals<br />
Green Chemicals<br />
Food Ingredients<br />
Cosmetic Ingredients<br />
Polymers & Resins<br />
© Coherent market Insights. All Rights Reserved
ABOUT COHERENT MARKET INSIGHTS<br />
KEY STATS<br />
100+<br />
Insights Published Per Year<br />
150+<br />
Consulting Projects Till Date<br />
125+<br />
Clients Worldwide Per Year<br />
RESEARCH SOLUTIONS<br />
CONSULT<br />
PROJECTS<br />
SURVEY<br />
RESEARC<br />
H<br />
FEASIBILITY<br />
STUDIES<br />
EXCEL<br />
FORECAST<br />
DATABASE<br />
GLOBAL<br />
REPORTS<br />
COUNTRY<br />
ANALYSIS<br />
CUSTOMIZED<br />
SOLUTIONS<br />
COMPETITIVE<br />
ASSESSMENT<br />
110+<br />
Analysts <strong>and</strong> Contract Consultants<br />
TECHNOLOGY<br />
SNIPPETS<br />
Coherent <strong>Market</strong> Insights excels at offering unmatched actionable market intelligence across various industry verticals, including chemicals, healthcare, <strong>and</strong><br />
food & beverages, to name a few. We implement holistic market research methodology in order to result in the best possible market research reports across<br />
various industries worldwide. Based on our unmatched expertise across various industries—no matter how large or small, how complex or unique—we help our<br />
clients achieve better outcomes with uniquely designed <strong>and</strong> highly customized solutions. Our coverage includes insights that help our clients ensure sustained<br />
growth in developed markets <strong>and</strong> also key inputs to help them tap into emerging markets <strong>and</strong> exploit the plethora of opportunities posed therein.<br />
© Coherent market Insights. All Rights Reserved
To know more about us, visit our website:<br />
www.coherentmarketinsights.com<br />
For sales queries or new topics email us on:<br />
sales@coherentmarketinsights.com<br />
For other queries contact:<br />
Mr. Shah<br />
(Manager - Business Development)<br />
Coherent <strong>Market</strong> Insights<br />
sales@coherentmarketinsights.com<br />
+1-206-701-6702<br />
THANK YOU<br />
© Coherent market Insights. All Rights Reserved
Change language